Covered recipient · General Payments record
LYNDSEY A HALE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$8,068.69
- Reported across 286 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,387.24 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EMD Serono, Inc. | $636.00 | 7 |
| TG THERAPEUTICS, INC. | $269.42 | 2 |
| GENZYME CORPORATION | $262.14 | 3 |
| UCB, Inc. | $252.98 | 4 |
| Alexion Pharmaceuticals, Inc. | $244.85 | 2 |
| Celgene Corporation | $237.03 | 2 |
| Stryker Corporation | $163.86 | 2 |
| Amgen Inc. | $150.57 | 2 |
| Biogen, Inc. | $92.07 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $78.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $122.99 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093993038 | CMS |
| Alexion Pharmaceuticals, Inc. | $121.86 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093952754 | CMS |
| Amgen Inc. | $53.55 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111592958 | CMS |
| Amgen Inc. | $97.02 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111592960 | CMS |
| Biogen, Inc. | $92.07 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104838333 | CMS |
| Celgene Corporation | $124.99 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101081787 | CMS |
| Celgene Corporation | $112.04 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101081797 | CMS |
| EMD Serono, Inc. | $124.99 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120212964 | CMS |
| EMD Serono, Inc. | $129.79 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120230770 | CMS |
| EMD Serono, Inc. | $99.26 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120245395 | CMS |
| EMD Serono, Inc. | $46.99 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120251458 | CMS |
| EMD Serono, Inc. | $75.55 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120251760 | CMS |
| EMD Serono, Inc. | $59.38 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120277418 | CMS |
| EMD Serono, Inc. | $100.04 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120274296 | CMS |
| GENZYME CORPORATION | $19.21 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139847127 | CMS |
| GENZYME CORPORATION | $149.39 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139847163 | CMS |
| GENZYME CORPORATION | $93.54 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139847223 | CMS |
| Novartis Pharmaceuticals Corporation | $78.32 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086928189 | CMS |
| Stryker Corporation | $96.90 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119846917 | CMS |
| Stryker Corporation | $66.96 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119846919 | CMS |
| TG Therapeutics, Inc. | $157.46 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136881885 | CMS |
| TG Therapeutics, Inc. | $111.96 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136882025 | CMS |
| UCB, Inc. | $38.46 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143507819 | CMS |
| UCB, Inc. | $124.99 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143507826 | CMS |
| UCB, Inc. | $1.40 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143507833 | CMS |
| UCB, Inc. | $88.13 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143507838 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.